Bicocca Open Archive

Logo unimib boa
SINICO, RENATO ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.411
EU - Europa 5.656
AS - Asia 2.083
SA - Sud America 41
Continente sconosciuto - Info sul continente non disponibili 32
AF - Africa 16
OC - Oceania 16
Totale 25.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.998
IE - Irlanda 1.290
IT - Italia 1.286
CN - Cina 1.098
SE - Svezia 860
DE - Germania 618
HK - Hong Kong 525
CA - Canada 391
GB - Regno Unito 389
UA - Ucraina 307
TR - Turchia 241
FI - Finlandia 237
AT - Austria 183
FR - Francia 167
RU - Federazione Russa 155
VN - Vietnam 72
DK - Danimarca 60
JP - Giappone 51
IN - India 39
EU - Europa 30
NL - Olanda 22
ES - Italia 20
MX - Messico 18
BE - Belgio 17
AU - Australia 14
CL - Cile 14
IL - Israele 12
RO - Romania 12
BR - Brasile 10
SG - Singapore 9
CH - Svizzera 8
IR - Iran 7
CO - Colombia 6
KR - Corea 6
BG - Bulgaria 5
EG - Egitto 5
PT - Portogallo 5
EC - Ecuador 4
NO - Norvegia 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
GR - Grecia 3
HU - Ungheria 3
SA - Arabia Saudita 3
SC - Seychelles 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IQ - Iraq 2
KZ - Kazakistan 2
LB - Libano 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TN - Tunisia 2
AM - Armenia 1
BD - Bangladesh 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
ID - Indonesia 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 25.255
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.897
Woodbridge 2.065
Chandler 1.378
Dublin 1.228
Houston 1.224
Fairfield 1.043
Dearborn 832
Wilmington 790
Jacksonville 783
Ashburn 703
Princeton 540
Hong Kong 513
New York 509
Frankfurt am Main 479
Seattle 407
Cambridge 360
Milan 345
Nanjing 253
Lawrence 243
Altamura 211
Lachine 195
Vienna 182
Boardman 165
Beijing 140
Lissone 123
San Diego 110
Ottawa 100
Shanghai 84
Andover 83
Nanchang 76
Shenyang 70
Toronto 65
Hebei 60
Norwalk 59
Guangzhou 58
Falls Church 53
Jiaxing 42
Changsha 38
Tianjin 38
Washington 38
London 37
Mountain View 36
Helsinki 35
Dong Ket 33
Jinan 33
Chicago 32
Hefei 24
Redmond 24
Zhengzhou 24
Hangzhou 22
Philadelphia 20
Kunming 19
Pune 19
Brussels 17
Kocaeli 16
Los Angeles 16
Tokyo 16
Rome 15
Fremont 14
Tappahannock 13
Edmonton 12
Sacramento 12
San Mateo 12
Brescia 11
Kilburn 11
Auburn Hills 10
Taizhou 10
Caronno Pertusella 9
Detroit 9
Wuhan 9
Florence 8
Paris 8
Phoenix 8
Santa Monica 8
Hounslow 7
Melbourne 7
Olbia 7
Palermo 7
Paullo 7
Siena 7
Tel Aviv 7
Berlin 6
Fuzhou 6
Genoa 6
Genova 6
Kiev 6
Monza 6
Ningbo 6
Saint Louis 6
São Paulo 6
Turin 6
Verona 6
Bergamo 5
Chengdu 5
Lappeenranta 5
Leawood 5
Padova 5
Perugia 5
Rho 5
Saint Petersburg 5
Totale 20.339
Salva come PNG Salva come JPEG
Nome #
Modifications in peripheral-blood lymphocyte subpopulations induced by plasmapheresis and immunosuppressive drugs 358
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 297
MALDI imaging in Fabry nephropathy: a multicenter study 288
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 260
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 251
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 246
Microscopic Polyangiitis 245
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS 214
Rituximab as maintenance treatment for systemic Lupus ErythematosusA multicentre observational study of 147 patients 212
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 208
Kidney Involvement 208
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 196
117. Prediction of Long-Term Evolutionary Profiles in Eosinophilic Granulomatosis with Polyangiitis (Churg– Strauss) Based on Baseline and Follow-Up Characteristics 190
162. Cluster analysis to explore clinical subclassification of eosinophilic granulomatosis with polyangiitis (churg–strauss) 184
Renal involvement in Churg-Strauss syndrome 181
Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy 178
Low-dose rituximab is poorly effective in patients with primary membranous nephropathy 177
HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome 175
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 170
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis 168
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 164
Systemic Vasculitis and Pregnancy: A Multicenter Study on Maternal and Neonatal Outcome of 66 Prospectively Followed Pregnancies 160
Systemic Vasculitis and Pregnancy: a Multicenter Study On Maternal and Neonatal Outcome of 43 Prospectively Followed Pregnancies 158
Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients 154
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 147
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 147
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 147
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 146
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 144
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 144
255. Renal involvement in EGPA: a multicentre retrospective study of 63 cases 139
[OP.4B.05] MIR-30A-3P EXPRESSION IN THE HEARTS OF DIABETIC RATS 137
Lymphocyte populations in the peripheral blood from patients with IgA nephropathy 136
Multiple hepatic abscesses complicating continuous ambulatory peritoneal dialysis 136
Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis 135
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 134
RITUXIMAB AS MAINTENANCE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS 134
Sneddon's syndrome: clinical and immunohistochemical findings 134
Eosinophilic granulomatosis with polyangiitis (churg-straus syndrome) 132
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 130
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 130
FP165 Slowly progressive anca-associated glomerulonephritis: a multicentre study 129
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 126
Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases 126
Role and clinical significance of rheumatoid factors in glomerulonephritis 125
ANCA-associated vasculitis in childhood: Recent advances 125
Characterization of anti-myeloperoxidase antibodies in vasculitis 124
Immunology of membranous nephropathy: From animal models to humans 123
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 123
Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease) 122
Neutrophil Extracellular Traps in the Autoimmunity Context 122
Anticoagulant-related nephropathy: a pathological note 121
Clinical significance of autoantibodies to myeloperoxidase in vasculitic syndromes 120
alpha 1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications 119
ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE) 119
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 119
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 118
Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis [Position paper] 118
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 118
Microarray evaluation of allergen-specific IgE in eosinophilic granulomatosis with polyangiitis 118
Plasma-exchange and glomerulonephritis 117
Plasma-exchange in immunologically mediated glomerular diseases 116
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies 116
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 116
Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases 115
Specificity of anti-neutrophil cytoplasm antibodies (ANCA) in vasculitic syndromes 115
T-lymphocyte subsets in primary and secondary glomerulonephritis 114
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 110
Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: A comparison of different assays 110
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 109
Antinucleosome antibodies in primary antiphospholipid syndrome: A hint at systemic autoimmunity? 109
Spontaneous and pokeweed mitogen induced production of rheumatoid factor and immunoglobulins in type II essential mixed cryoglobulinaemia 108
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide 108
L5. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 108
Effect of a continuous blood-cell separator and a polypropilene plasma filter on complement and platelet activation 108
The subclavian vein as an emergency vascular access for hemodialysis and plasma exchange 107
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 106
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 106
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 105
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 103
Renal vasculitis 103
Role of monocytes in extracapillary glomerulonephritis (gn) - histochemical-study in 15 patients 103
Infectious serologies and autoantibodies in wegener's granulomatosis and other vasculitides: Novel associations disclosed using the rad BioPlex 2200 102
FP216Renal involvement in EGPA : a multicentre retrospective study of 63 cases 102
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 102
Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies 101
Immunoglobulin heavy chain switch region gene polymorphisms in glomerulonephritis 101
ANCA-associated vasculitides (AAV) from the gender point of view 101
Meningeal involvement in apparently ANCA-negative Wegener's granulomatosis: A role for PR3 capture-ELISA? [1] 100
B lymphocyte subpopulations and T-cell subsets in primary chronic glomerulonephritis 100
European consensus statement on the terminology used in the management of lupus glomerulonephritis 99
The kaleidoscopic manifestations of systemic vasculitis 99
Detection of anti-IFI16 antibodies by ELISA: Clinical and serological associations in systemic sclerosis 99
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 99
Defective t-suppressor activity in type-i membranoproliferative glomerulonephritis (mpgn-i) 98
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy 98
Anti-C1q autoantibodies in lupus nephritis: Prevalence and clinical significance 98
Clinical nephrology-epidemiology-clinical trials: Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients 96
Treatment and monitoring of systemic vasculitis 96
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells 96
Totale 13.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019691 0 0 0 0 0 0 0 0 0 120 263 308
2019/20203.799 650 155 211 233 369 595 508 230 216 145 365 122
2020/20213.779 118 120 469 425 235 388 519 375 381 294 184 271
2021/20222.909 153 295 405 193 210 197 143 152 134 167 311 549
2022/20234.857 662 1.283 345 373 420 819 48 227 410 40 146 84
2023/20243.213 127 127 134 146 526 951 762 94 328 18 0 0
Totale 26.556